148 related articles for article (PubMed ID: 20831839)
1. Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.
Chintamani ; Kulshreshtha P; Chakraborty A; Singh L; Mishra AK; Bhatnagar D; Saxena S
World J Surg Oncol; 2010 Aug; 8():64. PubMed ID: 20831839
[TBL] [Abstract][Full Text] [Related]
2. Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women.
Singh LC; Chakraborty A; Mishra AK; Devi TR; Sugandhi N; Chintamani C; Bhatnagar D; Kapur S; Saxena S
Med Oncol; 2012 Jun; 29(2):539-46. PubMed ID: 21528410
[TBL] [Abstract][Full Text] [Related]
3. The polymorphism of CAG repeats in the androgen receptor gene and breast cancer mortality.
Lee YT; Liu HM; Lee LH; Liu CJ; Lin JS; Chao TC; Tzeng WF; Chiou TJ
Cancer Biomark; 2015; 15(6):815-22. PubMed ID: 26406407
[TBL] [Abstract][Full Text] [Related]
4. Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.
Mishra AK; Agrawal U; Negi S; Bansal A; Mohil R; Chintamani C; Bhatnagar A; Bhatnagar D; Saxena S
Indian J Med Res; 2012 Jun; 135(6):843-52. PubMed ID: 22825604
[TBL] [Abstract][Full Text] [Related]
5. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
6. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.
Yu H; Bharaj B; Vassilikos EJ; Giai M; Diamandis EP
Breast Cancer Res Treat; 2000 Jan; 59(2):153-61. PubMed ID: 10817350
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.
Witzel I; Graeser M; Karn T; Schmidt M; Wirtz R; Schütze D; Rausch A; Jänicke F; Milde-Langosch K; Müller V
J Cancer Res Clin Oncol; 2013 May; 139(5):809-16. PubMed ID: 23392859
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial.
Witzel I; Loibl S; Wirtz R; Fasching PA; Denkert C; Weber K; Lück HJ; Huober J; Karn T; Mackelenbergh MV; Marmé F; Schem C; Stickeler E; Untch M; Müller V
Br J Cancer; 2019 Dec; 121(12):1009-1015. PubMed ID: 31728025
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.
Spurdle AB; Dite GS; Chen X; Mayne CJ; Southey MC; Batten LE; Chy H; Trute L; McCredie MR; Giles GG; Armes J; Venter DJ; Hopper JL; Chenevix-Trench G
J Natl Cancer Inst; 1999 Jun; 91(11):961-6. PubMed ID: 10359549
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Importance of Androgen Receptor Status in Response to Neoadjuvant Chemotherapy in Turkish Patients with Local and Locally Advanced Breast Cancer.
Arici S; Sengiz Erhan S; Geredeli C; Cekin R; Sakin A; Cihan S
Oncol Res Treat; 2020; 43(9):435-440. PubMed ID: 32570261
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
14. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
[TBL] [Abstract][Full Text] [Related]
15. Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
Jongen L; Floris G; Wildiers H; Claessens F; Richard F; Laenen A; Desmedt C; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; Neven P
Breast Cancer Res Treat; 2019 Aug; 176(3):699-708. PubMed ID: 31106385
[TBL] [Abstract][Full Text] [Related]
16. Prediction of recurrence of non-muscle invasive bladder cancer: The role of androgen receptor and miRNA-2909.
Muzaail HH; El-Assmy A; Harraz AM; Awadalla A; Shokeir AA; Abdel-Aziz AF
Urol Oncol; 2022 May; 40(5):197.e25-197.e35. PubMed ID: 35430138
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Spurdle AB; Antoniou AC; Duffy DL; Pandeya N; Kelemen L; Chen X; Peock S; Cook MR; Smith PL; Purdie DM; Newman B; Dite GS; Apicella C; Southey MC; Giles GG; Hopper JL; Chenevix-Trench G; Easton DF;
Breast Cancer Res; 2005; 7(2):R176-83. PubMed ID: 15743497
[TBL] [Abstract][Full Text] [Related]
19. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
